The initiation of NLRP3 inflammasome in endothelial cells under pathophysiological conditions may exacerbate endothelial weakness, prompting hypertension, obesity, diabetes, neuroinflammation, retinopathy, atherosclerosis, cerebrovascular accident and malignancy. The gene discussed is NLRP3; the disease is obesity disorder.